Astria Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.341; its P/E ratio is -4.12; Astria Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -17.73M	$ -12.57M	$ -11.19M	-	$ -12.39M
EBITDA	$ -17.73M	$ -12.57M	$ -11.19M	-	$ -12.39M
Net Income Common Stockholders	$ -17.73M	$ -12.57M	$ -11.19M	-	$ -12.00M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 188.81M	$ 202.96M	$ 213.33M	$ 226.44M	$ 116.57M
Total Assets	$ 193.86M	$ 207.05M	$ 218.24M	$ 230.63M	$ 119.82M
Total Debt	$ 488.00K	$ 643.00K	$ 794.00K	$ 939.00K	$ 1.08M
Net Debt	$ -188.32M	$ -202.31M	$ -212.53M	$ -225.50M	$ -115.49M
Total Liabilities	$ 9.38M	$ 6.65M	$ 6.88M	$ 9.42M	$ 6.95M
Stockholders Equity	$ 184.48M	$ 200.40M	$ 211.36M	$ 221.22M	$ 112.87M
Cash Flow	-
Free Cash Flow	$ -14.26M	$ -10.70M	$ -13.26M	-	$ -10.31M
Operating Cash Flow	$ -14.26M	$ -10.70M	$ -13.25M	-	$ -10.25M
Investing Cash Flow	$ -4.00K	$ -57.92M	$ 194.99M	-	$ 1.95M
Financing Cash Flow	$ 110.00K	$ 273.00K	$ 37.00K	-	$ 24.32M

Currency in USD

Astria Therapeutics Earnings and Revenue History

Income Statement >

Astria Therapeutics Debt to Assets

Balance Sheet >

Astria Therapeutics Cash Flow

Cash Flow >

Astria Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing